Pivot Bio has closed a $100 million series C funding round, which was co-led by repeat investments from Singapore state-owned investment company Temasek and Breakthrough Energy Ventures, the biotech fertilizer company said Thursday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
